Breast cancer risk assessment: moving beyond BRCA 1 and 2

J Scalia-Wilbur, BL Colins, RT Penson… - Seminars in radiation …, 2016 - Elsevier
The National Cancer Institute estimates that 12.3% of all women (about 1 in 8) would be
diagnosed with breast cancer throughout their lifetime. In 2015, a projected 231,840 new …

Adherence patterns to National Comprehensive Cancer Network (NCCN) guidelines for referral to cancer genetic professionals

T Febbraro, K Robison, JS Wilbur, J Laprise… - Gynecologic …, 2015 - Elsevier
Objective Genetic predisposition is responsible for 5–10% of breast cancer, 10% of ovarian
cancer and 2–5% of uterine cancer. The study objective was to compare genetic counseling …

Preoperative genetic testing affects surgical decision making in breast cancer patients

E Lokich, A Stuckey, C Raker, JS Wilbur, J Laprise… - Gynecologic …, 2014 - Elsevier
Objectives Our aim was to determine if BRCA mutation status changes surgical decision
making in women who undergo genetic testing after the diagnosis of breast cancer. Methods …

The impact of converting to telehealth for cancer genetic counseling and testing during the COVID‐19 pandemic

EM Proussaloglou, EL Koelliker… - Journal of Genetic …, 2023 - Wiley Online Library
The COVID‐19 outbreak in March 2020 resulted in a shift to telemedicine for cancer genetic
counseling (GC). The objective of this study was to determine the effect of telehealth (TH) …

Clinical characteristics and choices regarding risk-reducing surgery in BRCA mutation carriers

A Stuckey, D Dizon, J Scalia Wilbur, J Kent… - Gynecologic and …, 2010 - karger.com
Background/Aims: BRCA mutation carriers have a high lifetime risk of developing breast and
ovarian malignancies. As genetic testing becomes widely available, preventative measures …

A case of Peutz-Jeghers syndrome with breast cancer, bilateral sex cord tumor with annular tubules, and adenoma malignum caused by STK11 gene mutation

A Clements, K Robison, C Granai… - International Journal of …, 2009 - ijgc.bmj.com
Background: Peutz-Jeghers syndrome (PJS) is a rare autosomal dominant disorder, and
women with this syndrome are at an increased risk of developing intestinal and …

[HTML][HTML] Choosing high-risk screening vs. surgery and the effect of treatment modality on anxiety and breast-specific sensuality in BRCA mutation carriers

KE Rojas, E Butler, J Gutierrez, R Kwait, J Laprise… - Gland …, 2019 - ncbi.nlm.nih.gov
Background We have previously shown that breast cancer surgery affects breast specific
sensuality, and that women who undergo mastectomy may have worse sexual function …

Barriers to hormone therapy following prophylactic bilateral salpingo-oophorectomy in BRCA1/2 mutation carriers

JB DiSilvestro, J Haddad, K Robison, L Beffa… - Menopause, 2023 - journals.lww.com
Objective This study aimed to identify barriers to hormone therapy (HT) use among women
with BRCA1/2 mutations after prophylactic bilateral salpingo-oophorectomy (BSO). Methods …

Ovarian Cancer Risk-Reduction and Screening in BRCA1/2 Mutation Carriers

JB DiSilvestro, J Haddad, K Robison… - Journal of Women's …, 2024 - liebertpub.com
Objective: To determine the utilization of risk-reducing strategies and screening protocols for
ovarian cancer in female BRCA1/2 carriers. Methods: This study was a sub-analysis of …

Financial toxicity in BRCA1 and BRCA2 carriers

EM Proussaloglou, AE Rosenthal, CA Raker… - Gynecologic …, 2023 - Elsevier
Objective Financial toxicity (FT), the cumulative financial burden experienced due to medical
care, is a well-established adverse effect of healthcare. Patients with BRCA mutations have …